Chapters

Transcript

Video

A Paradigm Shift in the Treatment of Prematurity: The Artificial Placenta

Babies born at less than 28 weeks gestation face particularly high mortality and morbidity, with significant medical challenges facing survivors.  Extracorporeal support presents a promising opportunity to support organ development for extremely premature infants.

Researchers at the University of Michigan are working to improve survival rates in the tiniest, most premature babies in a groundbreaking way: through an artificial placenta that mimics the womb.

George Mychaliska, MD, is a fetal surgeon in the division of pediatric surgery and director of the Fetal Diagnosis and Treatment Center at University of Michigan.

Presented at the Joint Conference on Advances in Pediatric Cardiovascular Disease Management.

Learn more about the Fetal Diagnosis and Treatment Center at www.mottchildren.org/fetalcenter

This presentation is part of the Joint Conference on Advances in Pediatric Cardiovascular Disease Management 2017. Learn more about the additional presentations in this series.

Related Presenters

George Mychaliska, MD.

George Mychaliska, MD

George B. Mychaliska, M.D. is currently an Assistant Professor of Surgery and Obstetrics and Gynecology at the University of Michigan. He earned his Medical Degree and Masters of Science from the Joint Medical Program at the University ...

View full profile